Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nathan

Showing results (511-520 of 635) with videos related to

Pageof 64
Sort By:
JAMA|January 14, 2000
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring StudyJ B Meigs, M A Mittleman, D M Nathan, et al.
The New England Journal of Medicine|July 21, 2006
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Nick Bayley, et al.
Journal of Neurosurgery|May 10, 2022
Decompressive hemicraniectomy and cranioplasty using subcutaneously preserved autologous bone flaps versus synthetic implants: perioperative outcomes and cost analysisEhsan Dowlati, Kory B Dylan Pasko, Esteban A Molina, et al.
Genitourinary Medicine|December 1, 1994
A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminataD K Armstrong, R D Maw, W W Dinsmore, et al.
Diabetes|March 29, 2005
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention ProgramWilliam C Knowler, Richard F Hamman, Sharon L Edelstein, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2008
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemiaBenjamin G Hassid, M Nathan Nair, Andrew F Ducruet, et al.
Metabolism: Clinical and Experimental|October 23, 2009
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humansMarie-France Hivert, Lisa M Sullivan, Peter Shrader, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2007
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazoneJose C Florez, Kathleen A Jablonski, Maria W Sun, et al.
JAMA Pediatrics|February 6, 2013
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAaron S Kelly, Kyle D Rudser, Brandon M Nathan, et al.
Diabetologia|October 11, 2025
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes StudyWei Perng, Shiyu Shu, David M Nathan, et al.
Pageof 64

Showing results (511-520 of 635) with videos related to

Sort By:
Pageof 64
JAMA|January 14, 2000
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring StudyJ B Meigs, M A Mittleman, D M Nathan, et al.
The New England Journal of Medicine|July 21, 2006
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Nick Bayley, et al.
Journal of Neurosurgery|May 10, 2022
Decompressive hemicraniectomy and cranioplasty using subcutaneously preserved autologous bone flaps versus synthetic implants: perioperative outcomes and cost analysisEhsan Dowlati, Kory B Dylan Pasko, Esteban A Molina, et al.
Genitourinary Medicine|December 1, 1994
A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminataD K Armstrong, R D Maw, W W Dinsmore, et al.
Diabetes|March 29, 2005
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention ProgramWilliam C Knowler, Richard F Hamman, Sharon L Edelstein, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2008
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemiaBenjamin G Hassid, M Nathan Nair, Andrew F Ducruet, et al.
Metabolism: Clinical and Experimental|October 23, 2009
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humansMarie-France Hivert, Lisa M Sullivan, Peter Shrader, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2007
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazoneJose C Florez, Kathleen A Jablonski, Maria W Sun, et al.
JAMA Pediatrics|February 6, 2013
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAaron S Kelly, Kyle D Rudser, Brandon M Nathan, et al.
Diabetologia|October 11, 2025
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes StudyWei Perng, Shiyu Shu, David M Nathan, et al.
Pageof 64